Snowball logo
logo
2786_logo

KNOTUS Co.Ltd

278650 • KQ
₩6,310.00-₩220.00  (3.37%)
Estimate
Beta
-0.008
Growth
Revenue, YoY
-10.17%
Net income, YoY
18.35%
FCF, YoY
45.57%
About the company
Ticker
278650
ISIN
KR7278650007
Country
South Korea
Sector (GICS)
Energy
HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug development consulting and clinical trial services, and bioanalysis items. The company was formerly known as KNOTUS Co.,Ltd. HLB bioStep Co.,Ltd. was founded in 2012 and is headquartered in Incheon, South Korea.

Frequently asked questions

What sector does KNOTUS Co.Ltd (278650) operate in?

KNOTUS Co.Ltd belongs to the Energy sector and operates in the Biotechnology industry.

What is KNOTUS Co.Ltd (278650) current stock price?

As of the latest data, KNOTUS Co.Ltd stock price is ₩6,310, with a previous close of ₩6,530. KNOTUS Co.Ltd lost -₩220 in the last trading session, representing a -3.37% loss.

What is KNOTUS Co.Ltd (278650) current market capitalization?

KNOTUS Co.Ltd market cap is approximately 108.62 billion.

Does KNOTUS Co.Ltd (278650) pay dividends?

No. KNOTUS Co.Ltd does not pay a dividend.

What is KNOTUS Co.Ltd (278650) beta (volatility) score?

KNOTUS Co.Ltd has a beta of -0.008, indicating lower volatility than the overall market.